11:59 AM
 | 
Nov 13, 2017
 |  BC Extra  |  Politics & Policy

Ex-Lilly president to be nominated as HHS secretary

President Donald Trump Monday announced on Twitter that he intends to nominate Alex Azar as HHS secretary, and that he expects Azar to tackle prescription drug prices. “He will be a star for better healthcare and lower drug prices!”

Azar’s resume includes over eight years at Eli Lilly and Co. (NYSE:LLY), where he served as president from January 2012 through January 2017. He was deputy secretary of HHS during 2005-07 following a four-year stint as HHS general counsel. Azar served on the board, executive committee and was co-chair of the Reimbursement Committee at BIO from 2013 to January 2017.

Senate Finance Committee Chairman Orrin Hatch (R-Utah) praised Azar in a statement, noting his opposition to the Affordable Care Act. “The leader of HHS will be at the tip of the spear, working to not only...

Read the full 653 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >